This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Yosuke Yamaura: Innovator in Bicyclic Pyrimidine Derivatives
Introduction
Yosuke Yamaura is a notable inventor based in Ichikawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of bicyclic pyrimidine derivatives. His work focuses on compounds that have potential therapeutic applications, especially in treating diseases related to T cells.
Latest Patents
Yamaura holds a patent for bicyclic pyrimidine derivatives, which are represented by a specific formula. These compounds exhibit anti-inflammatory activities and modulation effects on TARC and MDC functions. They are particularly useful in treating and preventing allergic diseases, autoimmune diseases, and transplant rejection. His patent is a testament to his innovative approach in addressing complex medical challenges.
Career Highlights
Yosuke Yamaura is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its advancements in biotechnology and pharmaceuticals. His work at the company has allowed him to focus on research that bridges the gap between chemistry and medicine. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.
Collaborations
Yamaura has collaborated with esteemed colleagues such as Hitoshi Arai and Tsutomu Matsumura. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the pharmaceutical industry.
Conclusion
Yosuke Yamaura's contributions to the field of medicinal chemistry through his patented innovations highlight his role as a key inventor. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
